NBPF1, a tumor suppressor candidate in neuroblastoma, exerts growth inhibitory effects by inducing a G1 cell cycle arrest

被引:40
|
作者
Andries, Vanessa [1 ,2 ]
Vandepoele, Karl [1 ,2 ,5 ]
Staes, Katrien [1 ]
Berx, Geert [1 ,2 ]
Bogaert, Pieter [1 ,6 ]
Van Isterdael, Gert [1 ,7 ]
Ginneberge, Daisy [1 ]
Parthoens, Eef [2 ,8 ]
Vandenbussche, Jonathan [3 ,4 ]
Gevaert, Kris [3 ,4 ]
van Roy, Frans [1 ,2 ]
机构
[1] VIB, Inflammat Res Ctr, Ghent, Belgium
[2] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium
[3] VIB, Dept Med Prot Res, Ghent, Belgium
[4] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium
[5] Ghent Univ Hosp, Lab Mol Diagnost Hematol, Ghent, Belgium
[6] BARC Global Cent Lab, Ghent, Zwijnaarde, Belgium
[7] Univ Ghent, Dept Internal Med, B-9000 Ghent, Belgium
[8] VIB, BioImaging Core, Ghent, Belgium
基金
比利时弗兰德研究基金会;
关键词
NBPF; Cell cycle; G1; arrest; p53; p21; Tumor suppressor; Cancer; EXPRESSION; IDENTIFICATION; PATIENT; PROTEIN; S100P; GENE;
D O I
10.1186/s12885-015-1408-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: NBPF1 (Neuroblastoma Breakpoint Family, member 1) was originally identified in a neuroblastoma patient on the basis of its disruption by a chromosomal translocation t(1;17)(p36.2;q11.2). Considering this genetic defect and the frequent genomic alterations of the NBPF1 locus in several cancer types, we hypothesized that NBPF1 is a tumor suppressor. Decreased expression of NBPF1 in neuroblastoma cell lines with loss of 1p36 heterozygosity and the marked decrease of anchorage-independent clonal growth of DLD1 colorectal carcinoma cells with induced NBPF1 expression further suggest that NBPF1 functions as tumor suppressor. However, little is known about the mechanisms involved. Methods: Expression of NBPF was analyzed in human skin and human cervix by immunohistochemistry. The effects of NBPF1 on the cell cycle were evaluated by flow cytometry. We investigated by real-time quantitative RT-PCR the expression profile of a panel of genes important in cell cycle regulation. Protein levels of CDKN1A-encoded p21(CIP1/WAF1) were determined by western blotting and the importance of p53 was shown by immunofluorescence and by a loss-offunction approach. LC-MS/MS analysis was used to investigate the proteome of DLD1 colon cancer cells with induced NBPF1 expression. Possible biological interactions between the differentially regulated proteins were investigated with the Ingenuity Pathway Analysis tool. Results: We show that NBPF is expressed in the non-proliferative suprabasal layers of squamous stratified epithelia of human skin and cervix. Forced expression of NBPF1 in HEK293T cells resulted in a G1 cell cycle arrest that was accompanied by upregulation of the cyclin-dependent kinase inhibitor p21(CIP1/WAF1) in a p53-dependent manner. Additionally, forced expression of NBPF1 in two p53-mutant neuroblastoma cell lines also resulted in a G1 cell cycle arrest and CDKN1A upregulation. However, CDKN1A upregulation by NBPF1 was not observed in the DLD1 cells, which demonstrates that NBPF1 exerts cell-specific effects. In addition, proteome analysis of NBPF1-overexpressing DLD1 cells identified 32 differentially expressed proteins, of which several are implicated in carcinogenesis. Conclusions: We demonstrated that NBPF1 exerts different tumor suppressive effects, depending on the cell line analyzed, and provide new clues into the molecular mechanism of the enigmatic NBPF proteins.
引用
收藏
页数:25
相关论文
共 50 条
  • [1] NBPF1, a tumor suppressor candidate in neuroblastoma, exerts growth inhibitory effects by inducing a G1 cell cycle arrest
    Vanessa Andries
    Karl Vandepoele
    Katrien Staes
    Geert Berx
    Pieter Bogaert
    Gert Van Isterdael
    Daisy Ginneberge
    Eef Parthoens
    Jonathan Vandenbussche
    Kris Gevaert
    Frans van Roy
    BMC Cancer, 15
  • [2] Chibby interacts with NBPF1 and clusterin, two candidate tumor suppressors linked to neuroblastoma
    Vandepoele, Karl
    Staes, Katrien
    Andries, Vanessa
    Van Roy, Frans
    EXPERIMENTAL CELL RESEARCH, 2010, 316 (07) : 1225 - 1233
  • [3] Expression of the tumor suppressor ARHI inhibits the growth of pancreatic cancer cells by inducing G1 cell cycle arrest
    Lu, Xinqing
    Qian, Jiaming
    Yu, Yinhua
    Yang, Hong
    Li, Jingnan
    ONCOLOGY REPORTS, 2009, 22 (03) : 635 - 640
  • [4] Limb-bud and Heart (LBH) Functions as a Tumor Suppressor of Nasopharyngeal Carcinoma by Inducing G1/S Cell Cycle Arrest
    Liu, Qicai
    Guan, Xiaoying
    Lv, Jingli
    Li, Xiaoyan
    Wang, Yingfeng
    Li, Li
    SCIENTIFIC REPORTS, 2015, 5
  • [5] Telmisartan Exerts Cytotoxicity in Scirrhous Gastric Cancer Cells by Inducing G0/G1 Cell Cycle Arrest
    Tsujiya, Yoshie
    Yamamori, Motohiro
    Hasegawa, Ai
    Yamamoto, Yurie
    Yashiro, Masakazu
    Okamura, Noboru
    ANTICANCER RESEARCH, 2021, 41 (11) : 5461 - 5468
  • [6] Limb-bud and Heart (LBH) Functions as a Tumor Suppressor of Nasopharyngeal Carcinoma by Inducing G1/S Cell Cycle Arrest
    Qicai Liu
    Xiaoying Guan
    Jingli Lv
    Xiaoyan Li
    Yingfeng Wang
    Li Li
    Scientific Reports, 5
  • [7] Hydroxychloroquine inhibits the growth of lung cancer cells by inducing G1 cell cycle arrest and apoptosis
    Fu, Shuang
    Liu, Likun
    Wang, Yaoyao
    Liu, Wenlu
    Sun, Siyu
    Gao, Xiu li
    Zhu, Wenbin
    Yue, Liling
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 37 (05) : 981 - 991
  • [8] Chrysosplenetin B suppresses the growth of human prostate cancer cells by inducing G1 cell cycle arrest
    He, Gang
    Feng, Yanjiao
    Chen, Tangcong
    Zhang, Yiyuan
    Liang, Li
    Yan, Jun
    Song, Yanxia
    Chen, Fengzheng
    Liu, Wei
    BIOIMPACTS, 2025, 15
  • [9] Growth suppression by Lkb1 is mediated by a G1 cell cycle arrest
    Tiainen, M
    Ylikorkala, A
    Mäkelä, TP
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (16) : 9248 - 9251
  • [10] A constitutional translocation T(1;17)(P36.2;Q11.2) in a neuroblastoma patient disrupts NBPF1,a novel putative tumor suppressor gene
    Andries, Vanessa
    Vandepoele, Karl
    Staes, Katrien
    van Roy, Frans
    ACTA CLINICA BELGICA, 2008, 63 (01): : 56 - 56